Complex Indications For Drugs Have Lengthened Development Time – Tufts
Executive Summary
Increased complexity of therapeutic indications is one factor contributing to longer clinical development times for drugs, according to Tufts Center for the Study of Drug Development Director Kenneth Kaitin
You may also be interested in...
Drugs Should Get Longer Patents In Exchange For More Safety Data – Wood
Offering extended exclusivity, in advance, for drugs that address an unmet medical need could bring a necessary boost to research and development efforts, Vanderbilt University's Alastair Wood said
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011